RecruitingNCT06690099
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
Sponsor
Devyser Inc.
Enrollment
500 participants
Start Date
Apr 7, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria5
- Willing and able to provide written informed consent
- 18 years of age or older at enrollment
- Women with a viable pregnancy (with documented fetal heartbeat) between 12 weeks, 0 days and 28 weeks, 0 days gestational age
- Women with RhD negative antigen status by serology
- Willing to provide neonatal ABO and RhD genotyping status
Exclusion Criteria1
- \. Women with multiple gestation pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06690099
Related Trials
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
NCT061132372 locations
Automated Insulin for Management of Intrapartum Glycemia
NCT068833442 locations
Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management
NCT072248931 location
Pregnancy and Risk of Venous Thromboembolism
NCT036597081 location
Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients
NCT066700791 location